ClinicalTrials.Veeva

Menu

Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Graves' Ophthalmopathy

Study type

Observational

Funder types

Other

Identifiers

NCT02290704
2013MEKY039

Details and patient eligibility

About

Find if the retinal function is affected in both the nonsevere and the severe stage of Graves' ophthalmopathy (GO) by comparing the retinal oxygen saturation of GO patients with that of normal people.

Full description

Graves'ophthalmopathy (GO), also called thyroid-associated ophthalmopathy, is often mild and self-limiting, and probably declining in frequency, with only 3-5% of cases posing a threat to eyesight, remaining a pathogenetic enigma and a therapeutic dilemma. In its nonsevere expression, the symptoms and signs include Photophobia, Foreign body sensation, Eyelid retraction, increased intraocular pressure, Lagophthalmos, and Mild diplopia. In its severe expression, it is a disfiguring and invalidating disease with the optic nerve damaged. However, in this study, we want to find if the retinal vessels is affected in the early stage of the disease through observing the oxygen saturation of the retinal vessels and compare it with that of the normal people.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for GO patients:

  1. conforms to the diagnosis of Graves' ophthalmopathy;
  2. age > 18;
  3. volunteered to participate in this research, and sign the informed consent.

Inclusion Criteria for Control group:

  1. age > 18;
  2. diopter within + / - 3D;
  3. volunteered to participate in this research, and sign the informed consent.

Exclusion Criteria for GO patients:

  1. Fundus could not be seen clearly;
  2. pregnant and lactating women;
  3. could not tolerate the examination.

Exclusion Criteria for Control group:

  1. with severe systemic disease and cause eye lesions;
  2. have history of eye disease, ocular trauma and eye surgery impacting on visual function;
  3. pregnant and lactating women;
  4. could not tolerate the examination.

Trial design

200 participants in 2 patient groups

controls
Description:
People without eye disease
GO patients
Description:
patients with Graves' ophthalmopathy

Trial contacts and locations

1

Loading...

Central trial contact

Xiaonan Yang; Danping Huang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems